Critical

Tachyarrhythmia — acute approach

Rhythm framework · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A structured approach to any fast heart rate (> 100/min) in an adult. The FIRST and most important branch is STABLE vs UNSTABLE: adverse features — SHOCK (hypotension, pallor, sweating), myocardial ISCHAEMIA (chest pain/ECG), SYNCOPE, or acute HEART FAILURE — mandate immediate SYNCHRONISED DC CARDIOVERSION regardless of the rhythm label. If the patient is stable, classify from the 12-lead ECG by QRS WIDTH (narrow < 120 ms vs broad ≥ 120 ms) and REGULARITY (regular vs irregular) — this four-box grid points to the likely rhythm and the safe drug. This umbrella ties together the specific protocols (AF, atrial flutter, SVT, VT, pre-excited AF, etc.).

Red flags

  • Adverse features = UNSTABLE → synchronised DC cardioversion now (shock, ischaemia, syncope, heart failure)
  • Broad-complex tachycardia — assume VT; don’t give AV-nodal blockers
  • Irregular broad-complex — pre-excited AF or polymorphic VT (avoid AV-nodal blockers)
  • Polymorphic VT/torsades — IV magnesium, stop QT-prolonging drugs, correct electrolytes

Assessment

Differential diagnosis

  • Narrow & REGULAR: sinus tachycardia, SVT (AVNRT/AVRT), atrial flutter (often 2:1), atrial tachycardia
  • Narrow & IRREGULAR: atrial fibrillation, atrial flutter with variable block, multifocal atrial tachycardia
  • Broad & REGULAR: ventricular tachycardia (assume VT), or SVT with aberrancy/bundle branch block
  • Broad & IRREGULAR: AF with aberrancy or PRE-EXCITATION (WPW), polymorphic VT / torsades

Investigations

  • 12-lead ECG (the key test) plus continuous monitoring; rhythm strip through any intervention
  • Identify and treat PRECIPITANTS — ischaemia, sepsis, PE, thyrotoxicosis, electrolyte disturbance (K⁺/Mg²⁺), hypoxia, drugs/stimulants, bleeding/hypovolaemia
  • Bloods: electrolytes, magnesium, troponin, TFTs; assess haemodynamics
  • Establish IV access, oxygen if hypoxic, and get defibrillator/pads on early

Management

  • ABCDE and attach defibrillator/monitoring. Decide STABLE vs UNSTABLE by adverse features (shock, ischaemia, syncope, heart failure).
  • UNSTABLE → immediate SYNCHRONISED DC CARDIOVERSION (sedation/anaesthesia); for regular narrow-complex give adenosine only if it does not delay cardioversion; correct K⁺/Mg²⁺.
  • STABLE, NARROW & REGULAR → vagal manoeuvres, then ADENOSINE (diagnostic and often therapeutic); if it is flutter/atrial tachycardia, adenosine unmasks it and you rate-control.
  • STABLE, NARROW & IRREGULAR → usually AF/flutter: rate control (beta-blocker or rate-limiting calcium-channel blocker), address anticoagulation and the < 48 h/anticoagulated rule before cardioversion (see the AF protocol).
  • STABLE, BROAD → treat as VT until proven otherwise: correct electrolytes and give an antiarrhythmic (e.g. amiodarone) with expert help; for IRREGULAR broad-complex think PRE-EXCITED AF (avoid AV-nodal blockers — use procainamide/DC) or polymorphic VT/torsades (IV magnesium). Escalate to cardiology/EP.

Drugs & doses

Synchronised DC cardioversion — any UNSTABLE tachyarrhythmia
Adenosine — stable regular narrow-complex (diagnostic + therapeutic)
Rate control — beta-blocker or diltiazem/verapamil (AF/flutter; NOT in pre-excitation)
Amiodarone — stable broad-complex/VT (expert-guided); IV magnesium for torsades
AVOID AV-nodal blockers (adenosine, verapamil, diltiazem, beta-blockers, digoxin) in pre-excited AF

Disposition

Monitored bed/CCU; cardiology/EP for broad-complex, recurrent or pre-excited arrhythmias; treat the precipitant and arrange anticoagulation review for AF/flutter.

Complications & pitfalls

  • Haemodynamic collapse / cardiac arrest (VF, pulseless VT)
  • Myocardial ischaemia and heart failure from sustained tachycardia
  • Thromboembolism (AF/flutter)
  • Pro-arrhythmia from inappropriate drug choice (e.g. AV-nodal blocker in WPW)

Exam pearls

  • STABLE vs UNSTABLE first — adverse features (shock, ischaemia, syncope, heart failure) mean synchronised DC cardioversion whatever the rhythm.
  • Then use the 2×2 grid — QRS WIDTH (narrow/broad) × REGULARITY — to pick the rhythm and the safe drug.
  • Broad-complex = VT until proven otherwise; never give AV-nodal blockers to an irregular broad-complex (pre-excited AF).
  • Always hunt the precipitant — a fast rate is often a symptom (sepsis, PE, bleeding, thyrotoxicosis, electrolytes), and sinus tachycardia is treated by treating the cause, not the rate.
  • Correct potassium and magnesium early; magnesium is the treatment for torsades.

Approach any tachyarrhythmia by STABLE vs UNSTABLE (adverse features → immediate synchronised DC cardioversion), then, if stable, classify on the 12-lead by QRS width and regularity to choose therapy: vagal/adenosine for regular narrow-complex; rate control for AF/flutter; treat broad-complex as VT (amiodarone, expert help) and irregular broad-complex as pre-excited AF (no AV-nodal blockers) or torsades (magnesium). Always find and treat the precipitant. See the specific rhythm protocols for detail.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.